Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 4 (2) , 120-125
- https://doi.org/10.3816/cbc.2003.n.017
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chemotherapy for metastatic breast cancer–report of a European expert panelThe Lancet Oncology, 2002
- Phase II Trial of Gemcitabine plus Trastuzumab in Metastatic Breast Cancer Patients Previously Treated with Chemotherapy: Preliminary ResultsClinical Breast Cancer, 2002
- Cardiac Dysfunction in the Trastuzumab Clinical Trials ExperienceJournal of Clinical Oncology, 2002
- Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?Annals of Oncology, 2002
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugsOncogene, 1998
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958